| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |